Table 1.

Experimental groups and treatments

Experimental group	SNI	SCS	Antagonist
Naive	–	–	–
No-SCS	+	–	–
SCS + Veh	+	+	–
SCS + CTOP 3 μg	+	+	+
SCS + CTOP 10 μg	+	+	+
SCS + CTOP 30 μg	+	+	+
SCS + NTI 3 mg/kg	+	+	+
SCS + NTI 10 mg/kg	+	+	+
SCS + Nor-BNI 5.74 μg	+	+	+
SCS + Nor-BNI 22.96 μg	+	+	+